Asset Details
Do you wish to reserve the book?
Rev1Δwzm vaccine candidate is safe in young and adult sheep and protects against Brucella ovis infection in rams
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Rev1Δwzm vaccine candidate is safe in young and adult sheep and protects against Brucella ovis infection in rams
Do you wish to request the book?
Rev1Δwzm vaccine candidate is safe in young and adult sheep and protects against Brucella ovis infection in rams
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Rev1Δwzm vaccine candidate is safe in young and adult sheep and protects against Brucella ovis infection in rams
2024
Overview
Small ruminants affected by brucellosis, caused mainly by Brucella melitensis and B. ovis, suffer reproductive disorders, leading to significant economic losses worldwide. Vaccination is an essential tool to prevent the disease in ovine and caprine livestock, but the only vaccine recommended to date is B. melitensis Rev1, which in sheep is only safe for use in lambs aged 3–4 months. This restriction poses considerable practical challenges for the implementation of Rev1 in countries with endemic brucellosis and/or limited resources, where there is a need for mass vaccination with a safe vaccine to control the disease in both animals and humans. We recently developed a B. melitensis strain Rev1Δwzm showing superior vaccine properties in mice and safety in pregnant ewes. Here, we report that Rev1Δwzm (i) is safe in young and adult sheep, both male and female; (ii) induces a transient serological response in the Rose Bengal test in ≤50 % of sheep, confirmed to some extent by the complement fixation test, and a stronger, more persistent anti- rough-LPS response; and (iii) protects rams against a B. ovis challenge 25 weeks after vaccination. To resolve the problem of serological interference, the use of green fluorescent protein tagging strategy allowed us to identify vaccinated sheep with only a single inoculation. These results, together with the previously reported safety in pregnant ewes, position Rev1Δwzm as a firm vaccine candidate and a promising alternative to Rev1. Further experiments are warranted to assess its efficacy against B. melitensis in pregnant ewes.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Animals
/ Antibodies, Bacterial - blood
/ Antibodies, Bacterial - immunology
/ B. ovis
/ Brucella melitensis - genetics
/ Brucella melitensis - immunology
/ Brucella melitensis biovar Ovis
/ Brucella Vaccine - administration & dosage
/ Brucella Vaccine - immunology
/ Brucellosis - prevention & control
/ Efficacy
/ Female
/ females
/ goats
/ Male
/ Males
/ Safety
/ Serology
/ Sheep
/ Sheep Diseases - prevention & control
/ Vaccines
